Format

Send to

Choose Destination
J Biol Chem. 2018 Dec 31. pii: jbc.RA118.006848. doi: 10.1074/jbc.RA118.006848. [Epub ahead of print]

A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor α agonists.

Author information

1
Monash University.
2
Jawaharlal Nehru University, New Delhi.
3
Monash University, Australia.
4
Les Laboratories Servier.
5
Institut de Recherches Servier, Croissy-sur-Seine, France.
6
Monash Institute of Pharmaceutical Sciences, Monash University, Australia.
7
Medicinal Chemistry, Monash University, Australia.

Abstract

Peroxisome proliferator-activated receptor α (PPARα) is a transcriptional regulator of lipid metabolism. GW7647 is a potent PPARα agonist that must reach the nucleus to activate this receptor. In cells expressing human fatty acid-binding protein 1 (FABP1), GW7647 treatment increases FABP1's nuclear localization, and potentiates GW7647-mediated PPARα activation; GW7647 is less effective in cells that do not express FABP1. To elucidate the underlying mechanism, here we substituted residues in FABP1 known to dictate lipid signaling by other intracellular lipid-binding proteins. Substitutions of Lys-20 and Lys-31 to Ala in the FABP1 helical cap affected neither its nuclear localization nor PPARα activation. In contrast, Ala substitution of Lys-57, Glu-77, and Lys-96, located in the loops adjacent to the ligand-binding portal region, abolished both FABP1 nuclear localization and GW7647-induced PPARα activation, but had little effect on GW7647-FABP1 binding affinity. Using solution NMR spectroscopy, we determined the wildtype FABP1 structure and analyzed the dynamics in the apo and GW7647-bound structures of both the wildtype and the K57A/E77A/K96A triple mutant. We found that GW7647 binding causes little change in the FABP1 backbone, but solvent-exposes several residues in the loops around the portal region, including Lys-57, Glu-77, and Lys-96. These residues also become more solvent exposed upon binding of FABP1 with the endogenous PPARα agonist oleic acid. Together with previous observations, our findings suggest that GW7647 binding stabilizes a FABP1 conformation that promotes its interaction with PPARα. We conclude that full PPARα agonist activity of GW7647 requires FABP1-dependent transport and nuclear localization processes.

KEYWORDS:

GW7647; PPARα agonist; drug delivery; fatty acid binding protein; nuclear magnetic resonance (NMR); nuclear receptor; peroxisome proliferator-activated receptor (PPAR); protein structure; transcription factor

PMID:
30598509
DOI:
10.1074/jbc.RA118.006848
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center